Pharmaceutical
| Fri 28 Aug 2026
Munich, Aug. 29 -- Aurigene Oncology has submitted a patent application for Substituted Tricyclic Compounds as KRAS Degraders. Murray Jeremy, Raikar Sandeep, Cole David, Mukherjee Subhendu, Bui Minna, Abbineni Chandrasekhar, Simonovich Scott, Aeluri Madhu, Sherer Brian, Makkikoppa Vittalarao Ravindra, Green Evan, Ferreira Andrew..